Journal of Substance Abuse Treatment
Volume 34, Issue 2 , Pages 157-164 , March 2008

The interactive effects of antisocial personality disorder and court-mandated status on substance abuse treatment dropout

Received 5 October 2006 ,Revised 2 February 2007 ,Accepted 16 February 2007.

References 

  1. Abrams KM. The effect of co-occurring disorders on criminal career: Interaction of antisocial personality disorder, alcoholism, and drug disorders. International Journal of Law and Psychiatry. 1989;12:133–148
  2. Alterman AI, Rutherford MJ, Cacciola JS, McKay JR, Boardman CR. Prediction of 7 months methadone maintenance treatment response by four measures of antisociality. Drug and Alcohol Dependence. 1998;49:217–223
  3. American Psychiatric Association (APA) . Diagnostic and statistical manual of mental disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  4. Brooner RK, Greenfield L, Schmidt CW, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous drug abusers. American Journal of Psychiatry. 1993;150:53–58
  5. Brooner RK, Kidorf M, King VL, Stoller K. Preliminary evidence of good treatment response in antisocial drug abusers. Drug and Alcohol Dependence. 1998;49:249–260
  6. Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric substance use comorbidity among treatment seeking opioid abusers. Archives of General Psychiatry. 1997;54:71–80
  7. Brooner RK, Schmidt CW, Felch LJ, Bigelow GE. Antisocial behavior of intravenous drug abusers: Implications for a diagnosis of antisocial personality disorder: Increased HIV risk behavior. American Journal of Psychiatry. 1992;149:482–487
  8. Cacciola JS, Rutherford MJ, Alterman AI, McKay JR, Snider EC. Personality disorders and treatment outcome in methadone maintenance patients. Journal of Nervous and Mental Disease. 1996;184:234–239
  9. Carroll KM, Ball SA, Rounsaville BJ. A comparison of alternate systems for diagnosing antisocial personality disorder in cocaine abusers. Journal of Nervous and Mental Disease. 1993;181:436–443
  10. Compton WM, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry. 2003;160:890–895
  11. Compton WM, Cottler LB, Shillington AM, Price RK. Is antisocial personality disorder associated with increased HIV risk behaviors in cocaine users?. Drug and Alcohol Dependence. 1995;37:37–44
  12. Condelli WS, Hubbard RL. Relationship between time spent in treatment and client outcomes from therapeutic communities. Journal of Substance Abuse Treatment. 1994;11:25–33
  13. Cottler LB, Price RK, Compton WM, Mager DE. Subtypes of adult antisocial behavior among drug users. Journal of Nervous and Mental Disease. 1995;183:154–161
  14. Daughters SB, Lejuez CW, Bornovalova MA, Kahler C, Strong D, Brown R. Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. Journal of Abnormal Psychology. 2005;114:729–734
  15. Daughters, S. B., Sargeant, M., Bornovalova, M. A., Gratz, K. L., & Lejuez, C. W. (invited revision under review). The relationship between distress tolerance and antisocial personality disorder among male residential treatment seeking inner-city substance users. Journal of Personality Disorders.
  16. De Leon G. Legal pressure in therapeutic communities. Journal of Drug Issues. 1988;18:625–640
  17. Evans K, Sullivan J. Dual diagnoses: Counseling mentally ill substance abusers. New York: Guilford Press; 1990;
  18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002;
  19. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L. Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). Washington, DC: American Psychiatric Publishing; 1997;
  20. Forrest GG. Chemical dependency and antisocial personality disorder: Psychotherapy and assessment strategies. New York: Hawthorne Press; 1991;
  21. Gil K, Nolimal D, Crowley TJ. Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug and Alcohol Dependence. 1992;30:247–252
  22. Glass DJ, Marlowe DB. Comparing state agency mandated and voluntary outpatients treatment outcome and retention in a cocaine addiction program. In: Paper presented at the 1994 Biennial Conference of the American Psychology–Law Society, Santa Fe, NM. 1994;
  23. Gossop M, Marsden J, Stewart D, Treacy S. Change and stability of change after treatment of drug misuse 2-year outcome from the National Treatment Outcome Research Study (UK). Addictive Behaviors. 2002;27:155–166
  24. Greenberg W, Otero J, Villanueva L. Irregular discharges from a dual diagnosis unit. American Journal of Drug and Alcohol Abuse. 1994;20:355–371
  25. Harrell A. Drug courts and the role of graduated sanctions. National Institute of Justice research preview. Washington, DC: Government Printing Office; 1998;
  26. Harrell A, Cavanaugh S. Compliance with drug abstinence requirements during pretrial release: A comparison of graduated sanctions and treatment for drug felony defendants. In: Paper presented at the 47th Annual Meeting of the American Society of Criminology, Boston, MA. 1995;
  27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association. 1958;53:457–481
  28. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51:8–19
  29. King VL, Kidorf MS, Stoller KB, Carter JA, Brooner R. Influence of antisocial personality subtype on drug abuse treatment response. Journal of Nervous and Mental Disease. 2001;189:593–601
  30. Kirisci L, Vanyukov M, Dunn M, Tarter R. Item response theory modeling of substance use: An index based on 10 drug categories. Psychology of Addictive Behaviors. 2002;16:290–298
  31. Kokkevi A, Stefanis N, Anastasopoulous E, Kostogianni C. Personality disorders in drug abusers: Prevalence and their association with Axis I disorders as predictors of treatment retention. Additive Behaviors. 1998;23:841–853
  32. Langan PA, Cunniff MA. Recidivism of felons on probation, 1986–89. Washington, DC: U.S. Department of Justice; 1992;
  33. Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug and Alcohol Dependence. 1994;35:31–35
  34. Marlowe DB, Kirby KC, Festinger DS, Husband SD, Platt JJ. Impact of comorbid personality disorders and personality disorder symptoms on outcomes of behavioral treatment for cocaine dependence. Journal of Nervous and Mental Disease. 1997;185:483–490
  35. Martin B, Clapp L, Bialkowski D, Bridgeford D, Amponsah A, Lyons L, et al. Compliance to supervised disulfiram therapy: A comparison of voluntary and court-ordered patients. American Journal on Addictions. 2003;12:137–143
  36. Messina N, Farabee D, Rawson R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive–behavioral and contingency management interventions. Journal of Consulting and Clinical Psychology. 2003;71:320–329
  37. Messina N, Wish ED, Nemes S. Therapeutic community treatment for substance abusers with antisocial personality disorder. Journal of Substance Abuse Treatment. 1999;17:121–128
  38. Nielson AL, Scarpitti FR. Predicting retention in a therapeutic community for incarcerated substance abusers. Journal of Offender Rehabilitation. 2002;34:47–65
  39. Nurco DN, Hanlon TE, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behavioral Sciences and the Law. 1991;9:221–249
  40. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1:385–401
  41. Satel S. Drug treatment: The case for coercion. Washington, DC: American Enterprise Institute Press; 1999;
  42. Schnoll SH, Goldstein MR, Antes DE, Rinella VJ. The impact of legal involvement on substance abusers in a residential treatment setting. Corrective and Social Psychology. 1980;26:21–28
  43. Silverman K, Wong C, Umbricht-Schneiter A, Montoya I, Schuster C, Preston K. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. Journal of Consulting and Clinical Psychology. 1998;66:811–824
  44. Simpson DD, Joe GW, Brown BS. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 1997;11:294–307
  45. Valliant G. Sociopathy as a human process: A viewpoint. Archives of General Psychiatry. 1975;32:178–283
  46. Young D. Impacts of perceived legal pressure on retention in drug treatment. Criminal Justice and Behavior. 2002;29:27–55
  47. Young D, Belenko S. Program retention and perceived coercion in three models of mandatory drug treatment. Journal of Drug Issues. 2002;32:297–328
  48. Young D, Fluellen R, Belenko S. Criminal recidivism in three models of mandatory drug treatment. Journal of Substance Abuse Treatment. 2004;27:313–323

PII: S0740-5472(07)00062-1

doi: 10.1016/j.jsat.2007.02.007

Journal of Substance Abuse Treatment
Volume 34, Issue 2 , Pages 157-164 , March 2008

Article Tools

* Image Usage & Resolution